BioHealth News Archive

miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

After the race to find a COVID-19 vaccine, researchers set off to explore other disease areas with similar RNA vehicles. miRecule, a US biotechnology…

Read More
Virginia Workforce Award to AMPEL BioSolutions

Virginia Workforce Award to AMPEL BioSolutions

Virginia officials recognized AMPEL BioSolutions today for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area of precision medicine. The…

Read More
Baltimore’s AsclepiX Therapeutics Raises $10 Million to Advance Clinical Study

Baltimore’s AsclepiX Therapeutics Raises $10 Million to Advance Clinical Study

Perceptive Advisors leads round to execute study in patients with wet age-related macular degeneration (wet AMD) BALTIMORE, MD, July 26, 2023– AsclepiX Therapeutics, Inc., a…

Read More
Virginia’s Solar Biotech Acquires VC-Backed Digital Biotech Noblegen

Virginia’s Solar Biotech Acquires VC-Backed Digital Biotech Noblegen

NORTON, Va. and PETERBOROUGH, ON, July 25, 2023 /PRNewswire/ - Solar Biotech Inc., a Norton, Virginia-based provider of complete sustainable and scalable biomanufacturing solutions, continues to build out its vertically…

Read More
United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the United States Court of…

Read More
Fierce Biotech: Previous Crab Trap Winner Galen Robotics nets FDA de novo clearance for ENT surgery helper

Fierce Biotech: Previous Crab Trap Winner Galen Robotics nets FDA de novo clearance for ENT surgery helper

Galen Robotics has claimed a de novo device clearance from the FDA for its digital surgical assistant, designed to provide a helping hand during…

Read More
Apply Now for the 6th Annual BioHealth Capital Region Investor Conference: Uniting Visionary Entrepreneurs and Pioneering Investors for Transformative Funding

Apply Now for the 6th Annual BioHealth Capital Region Investor Conference: Uniting Visionary Entrepreneurs and Pioneering Investors for Transformative Funding

The 6th Annual BioHealth Capital Region Investor Conference is just around the corner! Taking place on September 21st, 2023, at the US Pharmacopeia, this…

Read More
FinaBio’s Andrew Lees Wins Derek Horton Award in Industrial Carbohydrate Chemistry

FinaBio’s Andrew Lees Wins Derek Horton Award in Industrial Carbohydrate Chemistry

Andrew Lees has received The Derek Horton Award in Industrial Carbohydrate Chemistry for outstanding contributions to industrial carbohydrate chemistry. The Derek Horton Award in…

Read More
Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use Authorization status, and will continue to…

Read More
TEDCO Announces FY24 Board of Directors

TEDCO Announces FY24 Board of Directors

Talented, diverse, and experienced leaders tapped to support Maryland’s economic engine for technology companies   COLUMBIA, Md. (July 20, 2023) – TEDCO, Maryland’s economic…

Read More
Baltimore’s Vita Therapeutics Collaborates with MilliporeSigma to Advance Preclinical Program for Vita’s Preclinical Cell Therapy for Limb-Girdle Muscular Dystrophy (LGMD2A)

Baltimore’s Vita Therapeutics Collaborates with MilliporeSigma to Advance Preclinical Program for Vita’s Preclinical Cell Therapy for Limb-Girdle Muscular Dystrophy (LGMD2A)

Licensing agreement utilizing MilliporeSigma’s CRISPR genome-editing technology supports the advancement of Vita’s pipeline‍Baltimore, MD, July 18, 2023 – Vita Therapeutics, Inc. today announced a…

Read More
Introducing the NCI Small Business Transition Grant: A Pathway for Academic Scientists to Entrepreneurship

Introducing the NCI Small Business Transition Grant: A Pathway for Academic Scientists to Entrepreneurship

The Small Business Transition Grant application period is now open, providing a valuable opportunity for early-career academic scientists to transition into entrepreneurship. Graduating students…

Read More
TEDCO Invests SSBCI Funding into Kalocyte, Inc.

TEDCO Invests SSBCI Funding into Kalocyte, Inc.

Maryland-based biotechnology business working to save lives through innovative solutions COLUMBIA, Md. (July 17, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced…

Read More
Global Breakthroughs for a Healthier Future – Registration for the 9th Annual BioHealth Capital Region Forum Now Live

Global Breakthroughs for a Healthier Future – Registration for the 9th Annual BioHealth Capital Region Forum Now Live

Get ready for an exceptional experience at the 9th Annual BioHealth Capital Region Forum. Registration is now live for this highly anticipated event, taking…

Read More
BizJournals: Johns Hopkins University partnership with the Maryland Innovation Initiative looks to eliminate risks mosquitoes bring

BizJournals: Johns Hopkins University partnership with the Maryland Innovation Initiative looks to eliminate risks mosquitoes bring

By Tammi Thomas - Chief Development and Marketing Officer – TEDCO July 15, 2023, 06:00am EDT - Summer is upon us. Warmer months in the…

Read More